Emerging talents in frontiers in pharmacology: pharmacogenetics and pharmacogenomics 2022

被引：0

作者：

Klomp, Sylvia D. ^{[1
]}

Alfirevic, Ana ^{[2
]}

机构：

[1] Leiden Univ, Clin Pharm & Toxicol, Med Ctr, Leiden, Netherlands

[2] Univ Liverpool, Dept Pharmacol & Therapeut, Liverpool, England

来源：

FRONTIERS IN PHARMACOLOGY | 2023年 / 14卷

关键词：

pharmacogenetics; pharmacogenomics; early career researcher; publications; future; HERITABILITY;

D O I：

10.3389/fphar.2023.1307602

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页数：3

共 10 条

[1] A nationwide survey of pharmacists' perception of pharmacogenetics in the context of a clinical decision support system containing pharmacogenetics dosing recommendations [J].

Bank, Paul C. D. ;

Swen, Jesse J. ;

Guchelaar, Henk-Jan .

PHARMACOGENOMICS, 2017, 18 (03) :215-225

[2]

Klein Kathrin, 2013, Frontiers in Genetics, V4, P12, DOI 10.3389/fgene.2013.00012

[3] Phenoconversion of Cytochrome P450 Metabolism: A Systematic Review [J].

Klomp, Sylvia D. ;

Manson, Martijn L. ;

Guchelaar, Henk-Jan ;

Swen, Jesse J. .

JOURNAL OF CLINICAL MEDICINE, 2020, 9 (09) :1-33

[4] Prediction of drug response and adverse drug reactions: From twin studies to Next Generation Sequencing [J].

Lauschke, Volker M. ;

Ingelman-Sundberg, Magnus .

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 130 :65-77

[5] Cytochrome P450 Structure, Function and Clinical Significance: A Review [J].

Manikandan, Palrasu ;

Nagini, Siddavaram .

CURRENT DRUG TARGETS, 2018, 19 (01) :38-54

[6] Heritability of Metoprolol and Torsemide Pharmacokinetics [J].

Matthaei, J. ;

Brockmoeller, J. ;

Tzvetkov, M. V. ;

Sehrt, D. ;

Sachse-Seeboth, C. ;

Hjelmborg, J. B. ;

Moeller, S. ;

Halekoh, U. ;

Hofmann, U. ;

Schwab, M. ;

Kerb, R. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2015, 98 (06) :611-621

[7] Addressing phenoconversion: the Achilles' heel of personalized medicine [J].

Shah, Rashmi R. ;

Smith, Robert L. .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2015, 79 (02) :222-240

[8] A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster-randomised crossover implementation study [J].

Swen, Jesse J. ;

van der Wouden, Cathelijne H. ;

Manson, Lisanne E. N. ;

Abdullah-Koolmees, Heshu ;

Blagec, Kathrin ;

Blagus, Tanja ;

Boehringer, Stefan ;

Cambon-Thomsen, Anne ;

Cecchin, Erika ;

Cheung, Ka-Chun ;

Deneer, Vera H. M. ;

Dupui, Mathilde ;

Ingelman-Sundberg, Magnus ;

Jonsson, Siv ;

Joefield-Roka, Candace ;

Just, Katja S. ;

Karlsson, Mats O. ;

Konta, Lidija ;

Koopmann, Rudolf ;

Kriek, Marjolein ;

Lehr, Thorsten ;

Mitropoulou, Christina ;

Rial-Sebbag, Emmanuelle ;

Rollinson, Victoria ;

Roncato, Rossana ;

Samwald, Matthias ;

Schaeffeler, Elke ;

Skokou, Maria ;

Schwab, Matthias ;

Steinberger, Daniela ;

Stingl, Julia C. ;

Tremmel, Roman ;

Turner, Richard M. ;

van Rhenen, Mandy H. ;

Fajardo, Cristina L. Davila ;

Dolzan, Vita ;

Patrinos, George P. ;

Pirmohamed, Munir ;

Sunder-Plassmann, Gere ;

Toffoli, Giuseppe ;

Guchelaar, Henk-Jan .

LANCET, 2023, 401 (10374) :347-356

[9] Toward predicting CYP2D6-mediated variable drug response from CYP2D6 gene sequencing data [J].

van der Lee, Maaike ;

Allard, William G. ;

Vossen, Rolf H. A. M. ;

Baak-Pablo, Renee F. ;

Menafra, Roberta ;

Deiman, Birgit A. L. M. ;

Deenen, Maarten J. ;

Neven, Patrick ;

Johansson, Inger ;

Gastaldello, Stefano ;

Ingelman-Sundberg, Magnus ;

Guchelaar, Henk-Jan ;

Swen, Jesse J. ;

Anvar, Seyed Yahya .

SCIENCE TRANSLATIONAL MEDICINE, 2021, 13 (603)

[10]

Zanger UM, 2018, ADV PHARMACOL, V83, P33, DOI 10.1016/bs.apha.2018.02.003

← 1 →